Pneumonia and Primary myelofibrosis


Primary myelofibrosis is reported only by a few people with Pneumonia.

The study analyzes which people have Primary myelofibrosis with Pneumonia. It is created by eHealthMe based on 4 people who have Primary myelofibrosis and Pneumonia from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

4 people who have Pneumonia and Primary Myelofibrosis are studied.

What is Pneumonia?

Pneumonia is found to be associated with 4,115 drugs and 4,489 conditions by eHealthMe.

What is Primary myelofibrosis?

Primary myelofibrosis (primary disorder of the bone marrow) is found to be associated with 1,072 drugs and 752 conditions by eHealthMe.

Number of Primary myelofibrosis in Pneumonia reports submitted per year:

Would you have Primary myelofibrosis when you have Pneumonia?

Common co-existing conditions for these people *:

  1. Urination - Painful: 2 people, 50.00%
  2. Infection: 2 people, 50.00%
  3. Blood Uric Acid Increased: 2 people, 50.00%
  4. Cardiac Failure Congestive: 2 people, 50.00%
  5. Constipation: 2 people, 50.00%
  6. Cough: 2 people, 50.00%
  7. Fever: 2 people, 50.00%
  8. Herpes Zoster: 2 people, 50.00%
  9. High Blood Pressure: 2 people, 50.00%
  10. Oedema (fluid collection in tissue): 2 people, 50.00%

Common drugs taken by these people *:

  1. Xanax: 2 people, 50.00%
  2. Vigamox: 2 people, 50.00%
  3. Vancomycin: 2 people, 50.00%
  4. Valacyclovir: 2 people, 50.00%
  5. Potassium: 2 people, 50.00%
  6. Plavix: 2 people, 50.00%
  7. Oxycodone And Acetaminophen: 2 people, 50.00%
  8. Medrol: 2 people, 50.00%
  9. Magnesium: 2 people, 50.00%
  10. Lidocaine And Prilocaine: 2 people, 50.00%

Common symptoms for these people *:

  1. Thrombocytopenia (decrease of platelets in blood): 2 people, 50.00%
  2. Splenomegaly (enlargement of spleen): 2 people, 50.00%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 50.00%
  4. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 50.00%
  5. Pain In Extremity: 2 people, 50.00%
  6. Myelosuppression (a decrease in the production of blood cells): 2 people, 50.00%
  7. Malignant Neoplasm Progression (cancer tumour came back): 2 people, 50.00%
  8. Hepatic Function Abnormal: 2 people, 50.00%
  9. Blood Lactate Dehydrogenase Increased: 2 people, 50.00%
  10. Anaemia (lack of blood): 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Primary myelofibrosis?

Check whether Primary myelofibrosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Primary myelofibrosis:

Common drugs associated with Primary myelofibrosis:

All the drugs that are associated with Primary myelofibrosis:

Common conditions associated with Primary myelofibrosis:

All the conditions that are associated with Primary myelofibrosis:

How the study uses the data?

The study is based on Primary myelofibrosis and Pneumonia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: